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Role of laminin in endothelial cell recognition and differentiation. The
vascular endothelium normally is maintained in a quiescent state, but
under certain conditions it is induced to undergo marked changes in
behavior and form new vascular structures. A complex interaction
among various growth and differentiation factors and the extracellular
milieu regulates this behavior. One series of signals affecting endothelial
behavior is provided by laminin, a major structural protein of basement
membrane. These signals have been studied using Matrigel, a reconsti-
tuted basement membrane preparation from the murine Englebreth-
Holm-Swarm sarcoma, in an in vitro assay of endothelial cell differen-
tiation. Three biologically-active sequences from the laminin molecule
have been evaluated. Synthetic peptides that include the sequences
-RGD-, -YIGSR-, and -SIKVAV- mediate, respectively, cell binding to
Matrigel, alterations in cell morphology, and induction of migration and
collagenase activity. Preliminary data indicate that observations made
with this system may be relevant to endothelial function in vivo.
Endothelial cell differentiation on Matrigel may thus be a useful in vitro
model for the study of certain steps in angiogenesis.
The vascular endothelium shows a markedly low turnover
rate in vivo under normal conditions [1]. It is comprised of
polarized epithelioid cells with distinct apical and basal cyto-
plasmic domains [2, 31. These cells are usually in a quiescent
state, reflecting the stability and integrity of the vascular wall.
They form complex cell-cell junctions, and secrete a basement
membrane [4, 5]. This homeostasis is altered in vessel injury,
such as that which occurs in physical trauma [6], atherosclero-
sis [7], or inflammation [8]. In addition, the presence of a tumor
[9] or abnormal production of regulatory growth factors [10]
may stimulate changes in endothelial cell behavior leading to
angiogenesis. Endothelial cells also become activated in the
vasculogenesis of embryonic development [5, 11—13]. Forma-
tion of new blood vessels is a desirable event in wound healing,
but is deleterious in, for example, the neovascularization of the
eye in diabetes mellitus. The understanding of key events and
factors that regulate the angiogenic process is a prerequisite for
developing and targeting the pharmacological means to control
it for therapeutic purposes.
De novo physiologic or pathologic vessel formation requires
five steps: (1) basement membrane surrounding the vessel is
degraded, allowing the endothelial cells to penetrate the con-
nective tissue stroma. Then, (2) endothelial cells migrate into
the interstitium, where (3) they proliferate. Subsequently, (4)
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the new cells realign to form a capillary structure. Finally, (5)
complex junctions form between the cells, and new basement
membrane is secreted basally [13]. The signals that regulate
vessel formation are currently under investigation. Many cell-
and tissue-specific factors, including lymphokines [14, 15],
heparin-binding growth factors [acidic fibroblast growth factor
(FGF), basic FGF, transforming growth factor (TGF)-p and
tumor necrosis factor (TNF)] [12, 13, 161, and cytokines [16—19]
have been shown to stimulate cell migration and proliferation in
vitro [12, 16, 20—25]. Although the relationship of these obser-
vations to the cascade of events that results in endothelial cell
differentiation in vivo is uncertain, initial efforts to develop in
vitro models of blood vessel formation suggest that these
factors do play a significant role in modulating angiogenic
behavior of endothelium. When endothelial cells are maintained
in a superconfluent state for an extended duration, capillary-like
structures form spontaneously [24, 26, 27]. Deprivation of
growth factors also initiates this behavior [28]. Similar struc-
tures form when endothelial cells are cultured on extracellular
matrix substrata such as collagen I, fibronectin and gelatin, or
on a fragment of aorta in a fibrin clot [11, 17, 29—311. In general,
this differentiation from actively growing cells to quiescent cells
in a capillary-like structure requires from two days to eight
weeks. These in vitro models, however, only partly duplicate in
vivo events. Not all endothelial cells in these models contribute
to the formation of tubes, and the "vessels" may be inside Out,
secreting basement membrane substances into the lumen [27].
Numerous studies have demonstrated that type IV collagen is
involved in endothelial cell attachment and migration [23, 25,
27]. The ability of this and other basement membrane substrata
to partially support endothelial cell differentiation suggests that
components of the extracellular matrix (ECM) play an impor-
tant part in angiogenesis. Indeed, the period of time required for
tube formation in the absence of exogenous basement mem-
brane may relate to the need for the endothelial cells to secrete
a critical amount of basement membrane (tube formation can be
blocked by inhibitors of protein syntheses). Further, the occur-
rence of vessel proliferation in injury, which likely deprives the
cells of their normal milieu, and in diseases such as diabetes
mellitus when basement membrane composition is altered [32],
suggests that abnormality or absence of basement membrane
matrix may in some way allow endothelial cell proliferation to
occur. The normally quiescent state of endothelium in the
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Laminin
CQAGTALBNPQ Bioactivity of laminin
peptides
YIGSR RGD SIKVAV
Adhesion ++ +++ ++
Morphology +++ + +++
Migration + + ++++
Growth 0 + 0
Differentiation +++ 0 ++
Collagenase ++ 0 ++++
Fig. 1. Schematic model of the laminin molecule. Globular and helical domains are indicated. The location of sequences used to construct
synthetic peptides, and relative activities of these peptides for several biological assays, are shown.
Table 1. Factors affecting tube formation by HUVEC on Matrigel
Substance added % Control
Protein synthesis, activation or cytoskeletal assembly
Cycloheximide 2 g/ml 50
Cytochalasin D JO g/ml 4
Colchicine 10 p.g/ml 40
Phorbol 10 nM 250
H-7 JO p.M 50
Cytokines
Interferon alpha 100 U 250
Interferon gamma 100 U 5
Matrix components
Cis-hydroxyproline 50 p.g/ml 61
Ascorbic acid 50 p.g/mI 145
Collagen IV 10 p.g added to the Matrigel 140
Anti-collagen IV antiserum (1:10) 70
Anti-laminin antiserum (1:50) <10
Anti-entactin antiserum (1:10) <10
Anti-fibronectin antiserum (1:10) 100
Anti-heparan sulfate proteoglycan (1:10) 65
Synthetic laminin-derived peptides
CTFALRGDNP 250 p.g 40
CDPYIGRC 250 p.g 60
CSARKQAASIKVAVSADR 250 p.g 40
presence of basement membrane also supports the notion that
ECM may play a role in regulating endothelial cell function.
This possibility has been studied in vitro using Matrigel, a
reconstituted matrix prepared from the Englebreth-Hoim-
Swarm (EHS) tumor [33]. Except for a relative decrease in the
amount of type IV collagen present, Matrigel contains similar
components to those found in most basement membranes.
Matrigel has been found to induce differentiation by a variety of
cell types. For example, mammary carcinoma cells form gland-
like structures that secrete casein into their lumens [34], and
bone cells form canaliculi [351. When human umbilical vein
endothelial cells (HUVEC) or microvascular endothelial cells
are seeded onto Matrigel, they form a network of capillary-like
structures within 18 hours [4]. Almost all of the cells in the
culture form tubes, and cross sections of these tubes indicate
that the cells are physiologically polarized with apical mi-
crovilli, secretory granules, and basal nuclei [36]. This process
mimics the endothelial cell alignment, cell-cell adhesion, lumen
formation, and basal secretion of basement membrane that
occurs during formation of new microvessels. Thus, culture of
HUVEC or other endothelial cells on Matrigel may serve as a
useful, rapid model for in vitro study of endothelial cell activity
in certain steps of angiogenesis.
Matrigel contains multiple potential signals for endothelial
cell differentiation. The growth-regulatory factors TGF-/3,
platelet-derived growth factor (PDGF), basic FGF, epidermal
growth factor (EGF), and insulin-like growth factor (IGF)-l are
present [37]. The highly anionic heparan sulfate proteoglycans
in ECM bind some of these factors and probably serve as a
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Fig. 2. Effect of the -51K VA V- peptide on endothelial cell morphology. All photographs are 200x, taken through a Hoffman system. A.
Appearance of cells cultured on plastic. B. Endothelial cells cultured on plastic in the presence of 200 g/ml -SIKVAV-. C and D. Tube formation
by HUVEC plated on Matrigel without (C) and in the presence of (D) exogenous -SIKVAV- peptide.
reservoir for them [38, 39]. FGF is known to promote angio-
genesis in a variety of in vitro and in vivo model systems. It is
not known if the FGF present in basement membranes is active
in the bound form or must be freed.
In addition to the effects of recognized growth factors, it is
likely that individual extracellular matrix proteins themselves
play a direct role in regulating endothelial behavior. One of the
most extensively studied of these is laminin. This protein is
composed of three chains designated A (Mr = 400,000), B 1 (Mr
= 210,000) and B2 (Mr = 200,000) (Fig. 1). While the intact
molecule has been shown to affect differentiation in several
systems [40, 41], our laboratory has focused more recently on
three specific peptide sequences within laminin. These have
previously been found to affect the behavior of other types of
cells. A portion of the laminin A chain, containing the -RGD-
(arginine-glycine-aspartic acid) sequence found in a large num-
ber of protein-cell attachment sites, mediates cell attachment to
laminin [42]. A second sequence, on the short arm of the
laminin B 1 chain, includes -YIGSR- (tyrosine-isoleucine-
glycine-serine-arginine) and is active for adhesion to laminin
and to Matrigel [43]. Most recently, a sequence near the
carboxy-terminal end of the laminin A chain containing
-SIKVAV- (serine-isoleucine-lysine-valinealanine-valine) has
been found to induce neurite outgrowth in neuronal cells [44]
and facilitate metastatic behavior by tumor cells [45]. Thus,
laminin contains multiple active sites for regulating cell behav-
ior. These sites also induce similar changes in endothelial cells
[4] which will be discussed further below.
Modulation of endothelial cell tube formation on Matrigel
A quantitative assay for tube-forming activity on Matrigel has
been developed. Matrigel, prepared from the EHS tumor by 2 M
urea extraction [46], is maintained frozen until use. When
thawed and maintained at 4°C, it remains in a liquid state. It
polymerizes into a gel when warmed to 37°C. To perform the
assay, 300 1 Matrigel is plated into wells on a 24-well culture
plate. After it has been allowed to gel for 30 minutes at 37°C,
40,000 endothelial cells (previously grown on plastic dishes) in
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Attractant
Fig. 3. Chemoattraction by the SIKVA V-containing peptide. Cells
were placed in the upper well of a Boyden chamber; in the lower well
were control medium, biologically active, laminin-derived synthetic
peptide (-RGD-, -YIGSR-, or -SIKVAV-), a permutation of the
-SIKVAV- peptide sequence, or endothelial cell growth supplement
(ECGS). See text for details of the experimental methods.
I ml of culture medium are plated onto the Matrigel substratum.
Eighteen hours later, the culture is fixed and stained, and the
area of tubes formed on the surface of the Matrigel is quanti-
tated utilizing an Optomax imaging system [391. This assay has
been used to investigate the effect of a number of agents on tube
formation (Table 1). Cycloheximide inhibits tube formation,
indicating that this process requires new protein synthesis.
Because of the requirement for structural change and formation
of tight junctions, it is not surprising that cytochalasin and
colchicine decrease tube-forming activity [36]. Phorbol esters
enhance tube formation, whereas the kinase inhibitor H-7
inhibits this process. Type I and Type II interferons have
opposite effects, with IFNa increasing and IFNy decreasing
tube area.
Cis-hydroxyproline is inhibitory in the assay, while ascorbic
acid moderately enhances tube formation, suggesting that col-
lagen synthesis is important in tube formation. When additional
type IV collagen is added to the Matrigel, tube formation is also
somewhat enhanced. Antisera to heparan sulfate proteogly-
cans, collagen IV or fibronectin have partial or no effect
compared to the profound inhibition caused by antisera raised
against either laminin or entactin. Taken together, these data
suggest that protein synthesis and an intact cytoskeleton are
required for tube formation, and that endothelial cells interact
with multiple components of Matrigel during this process.
These results also indicate that this in vitro assay system may
-SIKVAV-added to cell culture, ig
Fig. 4. Release of radio/abel from type IV collagen by serum-free
supernates of cultured HUVEC. Cells (1 x lOs) were cultured in 1 ml
serum-free medium in the presence of varying doses of -SIKVAV-
peptide. After 6 hours, the supernates were transferred to wells coated
with radiolabeled collagen IV. Results are expressed as fold increase
over release induced by unconditioned medium (control).
provide a quick, reliable assay for testing certain angiogenic
properties of biological and pharmacological agents.
Because of the known biological activities of the three
laminin-derived peptide sequences, their activity was tested in
the tube assay. The peptide CTFALRGDNP decreases tube
formation by blocking attachment of the endothelial cells to the
Matrigel. CDPGYIGSRC inhibits tube alignment and other
morphological changes associated with tube formation. The
effects of the CSARKQAASIKVAVSADR peptide are more
complex. Photography of endothelial cells plated on plastic in
the presence of -SIKVAV- peptide shows increased extension
of cytoplasmic processes (Fig. 2), and time-lapse photography
(D. Grant and L. Thompson, unpublished observation) shows
greater movement across the culture plate. On Matrigel, the
cells treated with SIKVAV-containing peptide sprout multiple,
spike-like projections and invade the surface of the substratum.
Clumps of cells that form the "hubs" of the tube network may
extend more processes than usual, but many of these appear to
terminate prematurely, perhaps after entering the Matrigel (Fig.
2). The overall result is a decrease in tube area as measured by
the Optomax system [47].
Effects of the -SIKVA V- peptide on endothelial cell function
The biological activity of the SIKVAV-containing, laminin-
derived synthetic peptide on endothelial cells is not confined to
the tube-forming assay. In the experiment shown in Figure 3,
endothelial cells were evaluated for migratory activity across a
Millipore filter in a Boyden chamber assay. The upper chamber
contained 2 x io HUVEC. After five hours at 37°C, 5% CO2,
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enter the Matrigel suggested that these cells may be producing
proteolytic activity. To test this hypothesis, supernates of cells
treated with the -SIKVAV- peptide were tested for the presence
of a substance that degrades type IV collagen, a substrate
chosen because it is relatively specific for basement membrane.
In the experiment shown in Figure 4, collagenolytic activity was
measured by release of radioactivity from a solid-phase, radio-
labeled collagen IV substrate. Degradation was slightly above
background in the presence of supernates from cells not ex-
posed to this peptide, indicating that a small amount of activity
was secreted constitutively by cultured endothelial cells. The
-SIKVAV- peptide had a dose-dependent stimulatory effect on
secreted proteolytic activity, with maximum effect at 400 /LgIml.
Thus, this peptide stimulates degradation of type IV collagen by
endothelial cells.
In vivo effects of the -SIKVA V- peptide
To determine whether the effects of the -SIKVAV- sequence
on activity of cultured endothelial cells might be extended to the
process of angiogenesis in vivo, a chick yolk sac membrane
(CYSM) assay is employed, Fertilized chicken eggs are re-
moved from their shells under sterile conditions and vascular-
ization of the CYSM is followed during embryogenesis. As
shown in Figure 5, when the -SIKVAV- peptide is placed near
the main vessel growing out into the CYSM, a large collateral
circulation develops in the area of the peptide. The vessels
involved are also more prominent and more tortuous than
usual. This finding suggests that, in addition to its activities in
vitro, the -SIKVAV- sequence appears to be at least partially
responsible for laminin-induced angiogenic activity in vivo,
Summary
Fig. S. Effects of -SIKVAV- on vascularization of chick yolk sac
membrane. The assay was prepared as described in the text. Peptide
was added at initiation of the assay and photographs were taken 24
hours later. NV, central vascular branch from embryo; PBS, phos-
phate-buffered saline; PA22, -SIKVAV- peptide.
the filters were removed and stained, and the number of cells
present on the underside of the filter were quantitated visually
through an inverted microscope. In this chemoattraction assay,
peptides incorporating the sequences -RGD- and -YIGSR-,
when placed in solution in the lower chamber, caused slight
increases in migration compared to controls. Some migration
was stimulated by endothelial cell growth supplement (Collabora-
tive Research, Bedford, Massachusetts, USA), an agent neces-
sary for culturing HUVEC that is prepared from bovine brain and
contains a variety of growth factors, including FGF. The greatest
increase in migration was caused by the peptide containing
SIKVAV. A control peptide including -KSAVQARIV-, repre-
senting a "scrambled" version of the SIKVAV sequence,
induced little migratory behavior. These findings confirm the
studies made with time-lapse photography and demonstrate that
the -SIKVAV- sequence stimulates endothelial cell migration.
The observation that endothelial cell processes appear to
A variety of stimuli appear to coordinately regulate the
process of endothelial cell differentiation on Matrigel. In addi-
tion to cytokines and other intercellular mediators, the struc-
tural proteins of basement membrane appear to have their own
regulatory potential. At least three bioactive peptide sequences
have been identified as participating in laminin-mediated effects
of Matrigel. The sequence containing -RGD- mediates cell
attachment, -YIGSR- mediates morphological changes, and
-SIKVAV- activates or enhances several biological processes
that may be important in endothelial cell differentiation. Pre-
liminary experiments suggest that observations made regarding
endothelial behavior on Matrigel may provide data relevant to
endothelial function in vivo. Further studies are in progress to
determine how this in vitro model can be applied in character-
izing diseases of neovascularization and in developing ap-
proaches to therapeutic manipulation of angiogenesis.
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